The Biomedical Translation Research Center of Academia Sinica, is proudly announcing the fifth National Biotechnology Research Park " Investment Promotion, Talent and Technology Matchmaking Conference (NBRP DEMO DAY)", focusing on three major elements that are essential for biomedical startups better to have, namely technology, funding, and talents. This year, we are honored to invite distinguished speakers, including Dr. Michael Lu, Dean of the School of Public Health at UC Berkeley, Dr. Pan-Chi Yang, Academician of Academia Sinica, and Dr. Shi-An Chen, Honorary Dean of Taichung Veterans General Hospital, to deliver keynote addresses sharing cutting-edge insights and valuable experiences. The Trend Forum will feature a distinguished panel of experts from domestic and international industry, government, academia, and research, including Gur Roshwalb, CEO of 1E Therapeutics, Dr. John Tsai, Partner at Syncona Limited, Dr. Jo Shen, Venture Partner at Vivo Capital LLC, along with Dr. Sherry Ku, CEO of Kuder Consulting Inc., Dr. Jeng Her, CEO of AP Biosciences, Dr. Shu-Jen Chen, CSO of AnHorn Medicines and Dr, Harvey Chin, Chairman of AGM International Group. These leaders will engage in a dynamic discussion to consolidate their profound insights, fostering interactive dialogue and igniting potential collaborations.

NBRP DEMO DAY continues to demonstrate the abundant biomedical translation energy that briming over the park. This annual event not only provides a stage for resident companies and domestic teams to perform, but facilitates effective communication and cooperation with investors and pharmaceutical companies, and eventually invigorate Taiwan’s biotech ecosystem. The two-day DEMO DAY includes six major themes: Keynote Speech &Trends Forum, Pitch Competition, International partners connection, Talent Match, One-on-One Partnering, and Poster Presentation. We sincerely invite you all to participate in this grand event!